Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.

Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese Joint Committee of Lung Cancer Registry.

J Thorac Oncol. 2018 Oct 10. pii: S1556-0864(18)33180-0. doi: 10.1016/j.jtho.2018.10.002. [Epub ahead of print]

PMID:
30316011
2.

Clinical evaluation of the utility of a flexible 19-gauge EBUS-TBNA needle.

Kinoshita T, Ujiie H, Schwock J, Fujino K, McDonald C, Lee CY, Gregor A, Tyan CC, Houston S, Czarnecka-Kujwa K, Asamura H, Yasufuku K.

J Thorac Dis. 2018 Apr;10(4):2388-2396. doi: 10.21037/jtd.2018.04.50.

3.

Reply to 'Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer'.

Tamaki Y, Itazawa T, Komiyama T, Nishimura Y, Nakayama Y, Ito H, Ohde Y, Kusumoto M, Sakai S, Suzuki K, Watanabe H, Asamura H.

J Radiat Res. 2018 Jul 1;59(4):524-525. doi: 10.1093/jrr/rry040. No abstract available.

4.

[Role of Surgery in Multimodality Treatment for Non-small Cell Lung Cancer;Current Status and Future Perspectives].

Shima T, Masai K, Hishida T, Kaseda K, Hashimoto K, Takahashi Y, Otsuka T, Asamura H.

Kyobu Geka. 2018 Apr;71(4):244-248. Japanese.

PMID:
29755096
5.

The 8th TNM edition for lung cancer: a critical analysis.

Van Schil PE, Rami-Porta R, Asamura H.

Ann Transl Med. 2018 Mar;6(5):87. doi: 10.21037/atm.2017.06.45. Review.

6.

Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study.

Zhong C, Sakurai H, Wei S, Fang W, Asamura H.

J Thorac Dis. 2018 Feb;10(2):991-998. doi: 10.21037/jtd.2018.01.63.

7.

Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist.

Nicholson AG, Tsao MS, Travis WD, Patil DT, Galateau-Salle F, Marino M, Dacic S, Beasley MB, Butnor KJ, Yatabe Y, Pass HI, Rusch VW, Detterbeck FC, Asamura H, Rice TW, Rami-Porta R.

Arch Pathol Lab Med. 2018 May;142(5):645-661. doi: 10.5858/arpa.2017-0245-RA. Epub 2018 Feb 26.

PMID:
29480761
8.

The IASLC Lung Cancer Staging Project: A Renewed Call to Participation.

Giroux DJ, Van Schil P, Asamura H, Rami-Porta R, Chansky K, Crowley JJ, Rusch VW, Kernstine K; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee.

J Thorac Oncol. 2018 Jun;13(6):801-809. doi: 10.1016/j.jtho.2018.02.012. Epub 2018 Feb 22.

9.

Radiologic-Pathologic Correlation of Solid Portions on Thin-section CT Images in Lung Adenocarcinoma: A Multicenter Study.

Yanagawa M, Kusumoto M, Johkoh T, Noguchi M, Minami Y, Sakai F, Asamura H, Tomiyama N; Investigators of JSTR Lung Cancer Working Group.

Clin Lung Cancer. 2018 May;19(3):e303-e312. doi: 10.1016/j.cllc.2017.12.005. Epub 2017 Dec 19.

10.

A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).

Hishida T, Saji H, Watanabe SI, Asamura H, Aokage K, Mizutani T, Wakabayashi M, Shibata T, Okada M; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG-LCSSG).

Jpn J Clin Oncol. 2018 Feb 1;48(2):190-194. doi: 10.1093/jjco/hyx170.

PMID:
29177507
11.

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.

Kinoshita T, Kudo-Saito C, Muramatsu R, Fujita T, Saito M, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Hayashi Y, Kaseda K, Kamiyama I, Ohtsuka T, Tomizawa K, Shimoji M, Mitsudomi T, Asamura H, Kawakami Y.

Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23.

PMID:
28950145
12.

Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer.

Masai K, Sakurai H, Sukeda A, Suzuki S, Asakura K, Nakagawa K, Asamura H, Watanabe SI, Motoi N, Hiraoka N.

J Thorac Oncol. 2017 Dec;12(12):1788-1797. doi: 10.1016/j.jtho.2017.08.015. Epub 2017 Sep 4.

13.

Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma.

Shiraishi H, Fujiwara Y, Kakuya T, Tsuta K, Motoi N, Miura N, Watabe Y, Watanabe SI, Noro R, Nagashima K, Huang W, Yamada T, Asamura H, Ohe Y, Honda K.

Biomark Med. 2017 Jun 29. doi: 10.2217/bmm-2017-0150. [Epub ahead of print]

PMID:
28658966
14.

Scientific Advances in Thoracic Oncology 2016.

Soo RA, Stone ECA, Cummings KM, Jett JR, Field JK, Groen HJM, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-Porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu YL, Higgins K, Senan S, Solomon B, Kim DW, Johnson M, Yang JCH, Sequist LV, Shaw AT, Ahn MJ, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-Finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR.

J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1. Review.

15.

Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma.

Yotsukura M, Yasuda H, Shigenobu T, Kaseda K, Masai K, Hayashi Y, Hishida T, Ohtsuka T, Naoki K, Soejima K, Betsuyaku T, Asamura H.

Lung Cancer. 2017 Jul;109:45-51. doi: 10.1016/j.lungcan.2017.04.014. Epub 2017 Apr 23.

PMID:
28577949
16.

Wedge Resection Versus Anatomic Resection: Extent of Surgical Resection for Stage I and II Lung Cancer.

Asamura H, Aokage K, Yotsukura M.

Am Soc Clin Oncol Educ Book. 2017;37:426-433. doi: 10.14694/EDBK_179730. Review.

17.

The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.

Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions.

J Thorac Oncol. 2017 Jul;12(7):1109-1121. doi: 10.1016/j.jtho.2017.04.011. Epub 2017 Apr 28.

18.

Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer.

Nakajima J, Iida T, Okumura S, Horio H, Asamura H, Ozeki Y, Ikeda N, Matsuguma H, Chida M, Otsuka H, Kawamura M; Metastatic Lung Tumor Study Group of Japan.

Eur J Cardiothorac Surg. 2017 May 1;51(5):869-873. doi: 10.1093/ejcts/ezw401.

PMID:
28369355
19.

The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: past activities, current status and future direction.

Nakagawa K, Watanabe SI, Kunitoh H, Asamura H.

Jpn J Clin Oncol. 2017 Mar 1;47(3):194-199. doi: 10.1093/jjco/hyw169. Review.

PMID:
28365781
20.

Thoracoscopic surgery versus open surgery for lung metastases of colorectal cancer: a multi-institutional retrospective analysis using propensity score adjustment†.

Murakawa T, Sato H, Okumura S, Nakajima J, Horio H, Ozeki Y, Asamura H, Ikeda N, Otsuka H, Matsuguma H, Yoshino I, Chida M, Nakayama M, Iizasa T, Okumura M, Shiono S, Kato R, Iida T, Matsutani N, Kawamura M, Sakao Y, Funai K, Furuyashiki G, Akiyama H, Sugiyama S, Kanauchi N, Shiraishi Y; Metastatic Lung Tumor Study Group of Japan.

Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1157-1163. doi: 10.1093/ejcts/ezx020.

PMID:
28329272
21.

A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211).

Aokage K, Saji H, Suzuki K, Mizutani T, Katayama H, Shibata T, Watanabe S, Asamura H; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.

Gen Thorac Cardiovasc Surg. 2017 May;65(5):267-272. doi: 10.1007/s11748-016-0741-1. Epub 2017 Mar 2.

PMID:
28255781
22.

Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Rami-Porta R, Asamura H, Travis WD, Rusch VW.

CA Cancer J Clin. 2017 Mar;67(2):138-155. doi: 10.3322/caac.21390. Epub 2017 Jan 31.

23.
24.

Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review.

Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M, Suzuki K, Watanabe S, Asamura H.

Jpn J Clin Oncol. 2017 Jan;47(1):7-11. doi: 10.1093/jjco/hyw148. Epub 2016 Oct 20. Review.

PMID:
27765813
25.

Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.

Kinoshita T, Muramatsu R, Fujita T, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Kudo-Saito C, Hayashi Y, Kamiyama I, Ohtsuka T, Asamura H, Kawakami Y.

Ann Oncol. 2016 Nov;27(11):2117-2123. Epub 2016 Aug 8.

PMID:
27502728
26.

The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.

Pass H, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Asamura H, Waller D, Edwards J, Weder W, Hoffmann H, van Meerbeeck JP, Nowak A, Rusch VW; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions.

J Thorac Oncol. 2016 Dec;11(12):2082-2088. doi: 10.1016/j.jtho.2016.09.123. Epub 2016 Sep 23. Review.

27.

Comment on the Proposals for the Revision of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Osarogiagbon RU, Smeltzer MP, Faris N, Rami-Porta R, Goldstraw P, Asamura H.

J Thorac Oncol. 2016 Oct;11(10):1612-4. doi: 10.1016/j.jtho.2016.06.008. No abstract available.

28.

The Japan Lung Cancer Society-Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer.

Itazawa T, Tamaki Y, Komiyama T, Nishimura Y, Nakayama Y, Ito H, Ohde Y, Kusumoto M, Sakai S, Suzuki K, Watanabe H, Asamura H.

J Radiat Res. 2017 Jan;58(1):86-105. doi: 10.1093/jrr/rrw076. Epub 2016 Sep 8.

29.

Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia Pattern.

Masai K, Tsuta K, Motoi N, Shiraishi K, Furuta K, Suzuki S, Asakura K, Nakagawa K, Sakurai H, Watanabe SI, Hiraoka N, Asamura H.

J Thorac Oncol. 2016 Dec;11(12):2141-2149. doi: 10.1016/j.jtho.2016.07.034. Epub 2016 Aug 27.

30.

Giant lamellar bodies associated with adenocarcinoma of the lung.

Shigenobu T, Motoi N, Asamura H, Watanabe SI, Hiraoka N, Yoshida A.

Histopathology. 2016 Dec;69(6):1090-1092. doi: 10.1111/his.13052. Epub 2016 Sep 27. No abstract available.

PMID:
27482850
31.

Staging, Tumor Profile, and Prognostic Groups in Lung Cancer or the New Tower of Babel.

Rami-Porta R, Asamura H, Brierley J, Goldstraw P.

J Thorac Oncol. 2016 Aug;11(8):1201-1203. doi: 10.1016/j.jtho.2016.04.019. No abstract available.

32.

Node Doubt: Rigorous Surgical Nodal Procurement Combined With Thorough Pathologic Evaluation Improves Non-Small Cell Lung Carcinoma Staging Accuracy.

Butnor KJ, Asamura H, Travis WD.

Ann Thorac Surg. 2016 Aug;102(2):353-6. doi: 10.1016/j.athoracsur.2016.05.075. No abstract available.

PMID:
27449422
33.

Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.

Filosso PL, Guerrera F, Thomas P, Brunelli A, Lim E, Garcia-Yuste M, Asamura H, Papagiannopoulos K, Sarkaria I, Venuta F; European Society of Thoracic Surgeons Neuroendocrine Tumors of the Lung Working Group.

Future Oncol. 2016 Sep;12(17):1985-99. doi: 10.2217/fon-2016-0092. Epub 2016 Jun 15.

PMID:
27301649
34.

Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.

Hishida T, Miyaoka E, Yokoi K, Tsuboi M, Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date H, Tada H, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry.

J Thorac Oncol. 2016 Sep;11(9):1529-37. doi: 10.1016/j.jtho.2016.05.014. Epub 2016 May 29.

35.

The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study.

Nakagawa K, Asamura H, Tsuta K, Nagai K, Yamada E, Ishii G, Mitsudomi T, Ito A, Higashiyama M, Tomita Y, Inoue M, Morii E, Matsuura N, Okumura M.

Lung Cancer. 2016 Jul;97:1-7. doi: 10.1016/j.lungcan.2016.03.015. Epub 2016 Mar 28.

PMID:
27237020
36.

Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer.

Yotsukura M, Ohtsuka T, Kaseda K, Kamiyama I, Hayashi Y, Asamura H.

J Thorac Oncol. 2016 Aug;11(8):1311-1318. doi: 10.1016/j.jtho.2016.04.029. Epub 2016 May 24.

37.

Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).

Eba J, Nakamura K, Mizusawa J, Suzuki K, Nagata Y, Koike T, Hiraoka M, Watanabe S, Ishikura S, Asamura H, Fukuda H; Lung Cancer Surgical Study Group and the Radiation Therapy Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2016 Aug;46(8):748-53. doi: 10.1093/jjco/hyw058. Epub 2016 May 12.

PMID:
27174959
38.

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, Goo JM, MacMahon H, Naidich D, Nicholson AG, Powell CA, Prokop M, Rami-Porta R, Rusch V, van Schil P, Yatabe Y; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members.

J Thorac Oncol. 2016 Aug;11(8):1204-1223. doi: 10.1016/j.jtho.2016.03.025. Epub 2016 Apr 21. Review.

39.

Ectopic Adrenocorticotropic Hormone-Secreting Bronchial Carcinoid Diagnosed by Balloon-Occluded Pulmonary Arterial Sampling.

Yotsukura M, Kohno M, Asakura K, Kamiyama I, Ohtsuka T, Hayashi Y, Kurihara I, Nakatsuka S, Asamura H.

Ann Thorac Surg. 2016 May;101(5):1963-5. doi: 10.1016/j.athoracsur.2015.04.117.

PMID:
27106427
40.

Scientific Advances in Lung Cancer 2015.

Tsao AS, Scagliotti GV, Bunn PA Jr, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS, Adusumilli PS, Rami-Porta R, Asamura H, Van Schil PE, Darling GE, Ramalingam SS, Gomez DR, Rosenzweig KE, Zimmermann S, Peters S, Ignatius Ou SH, Reungwetwattana T, Jänne PA, Mok TS, Wakelee HA, Pirker R, Mazières J, Brahmer JR, Zhou Y, Herbst RS, Papadimitrakopoulou VA, Redman MW, Wynes MW, Gandara DR, Kelly RJ, Hirsch FR, Pass HI.

J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22. Review.

41.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):651-665. doi: 10.1016/j.jtho.2016.01.025. Epub 2016 Mar 2.

42.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):681-692. doi: 10.1016/j.jtho.2015.12.114. Epub 2016 Mar 3.

43.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):639-650. doi: 10.1016/j.jtho.2016.01.024. Epub 2016 Mar 3.

44.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):666-680. doi: 10.1016/j.jtho.2015.12.113. Epub 2016 Mar 3.

45.

Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator.

Kurebayashi Y, Emoto K, Hayashi Y, Kamiyama I, Ohtsuka T, Asamura H, Sakamoto M.

Cancer Immunol Res. 2016 Mar;4(3):234-47. doi: 10.1158/2326-6066.CIR-15-0214. Epub 2016 Jan 19.

46.

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions.

J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.

47.

Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung.

Kamata T, Sunami K, Yoshida A, Shiraishi K, Furuta K, Shimada Y, Katai H, Watanabe S, Asamura H, Kohno T, Tsuta K.

J Thorac Oncol. 2016 Feb;11(2):261-5. doi: 10.1016/j.jtho.2015.10.021. Epub 2015 Dec 22.

48.

Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.

Kinoshita T, Fujii H, Hayashi Y, Kamiyama I, Ohtsuka T, Asamura H.

Lung Cancer. 2016 Jan;91:56-66. doi: 10.1016/j.lungcan.2015.11.020. Epub 2015 Nov 28.

PMID:
26711935
49.

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, Watanabe H, Wu YL, Zielinski M, Ball D, Rami-Porta R; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions.

J Thorac Oncol. 2015 Dec;10(12):1675-84. doi: 10.1097/JTO.0000000000000678. Review.

50.

Correction: Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner.

Kakinuma R, Moriyama N, Muramatsu Y, Gomi S, Suzuki M, Nagasawa H, Kusumoto M, Aso T, Muramatsu Y, Tsuchida T, Tsuta K, Maeshima AM, Tochigi N, Watanabe S, Sugihara N, Tsukagoshi S, Saito Y, Kazama M, Ashizawa K, Awai K, Honda O, Ishikawa H, Koizumi N, Komoto D, Moriya H, Oda S, Oshiro Y, Yanagawa M, Tomiyama N, Asamura H.

PLoS One. 2015 Dec 18;10(12):e0145357. doi: 10.1371/journal.pone.0145357. eCollection 2015. No abstract available.

Supplemental Content

Loading ...
Support Center